TRUSTPOLITICS
M

Member

Speaking in the House of Commons on 8 September 2026

Debate

Health Bill

Contribution

(2) Regulations under this section must ensure that such drugs cannot be given out or used as part of clinical trials for the treatment of gender dysphoria, gender incongruence or a combination of both, unless that trial has specifically been approved by a resolution of both Houses of Parliament.
← Previous speaker
In this debate
Next speaker →
In this debate

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.